Article Text


Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium


OBJECTIVE Previous studies have suggested that resting myocardial blood flow is within normal limits in most chronically dysfunctional left ventricular segments which improve function after coronary artery revascularisation (hibernating myocardium). The aim of this study was to assess myocardial blood flow and coronary vasodilator reserve in hibernating myocardium before and after coronary revascularisation.

PATIENTS AND METHODS 30 patients with multivessel coronary disease undergoing coronary revascularisation (21 patients with bypass grafting and nine with coronary angioplasty), and 21 age and sex matched healthy volunteers (controls). Myocardial blood flow (MBF, ml/min/g) was measured by positron emission tomography using oxygen-15 water at rest and after dipyridamole (MBFdip, 0.56 mg/kg in four minutes). Coronary vasodilator reserve was calculated as MBFdip/MBF. Regional wall motion was assessed with echocardiography.

RESULTS Before revascularisation there were 48 remote and 275 dysfunctional myocardial segments, of which 163 (59%) improved function after revascularisation (hibernating). In hibernating segments coronary vasodilator reserve before revascularisation was significantly lower than in remote segments (1.97 (0.7), p < 0.0001) and controls (3.2 (1.5), p < 0.0001). In hibernating segments, myocardial blood flow remained unchanged after revascularisation (0.94 (0.3)v 0.95 (0.3) ml/min/g, p = 0.3) while coronary vasodilator reserve increased (1.47 (0.7)v 1.98 (1.0), p < 0.0001). Myocardial blood flow was similar in remote, hibernating segments before and after revascularisation and in controls.

CONCLUSIONS This study confirms that myocardial blood flow at rest in hibernating myocardium is within normal limits in most segments, and that hibernating myocardium is characterised by an impaired coronary vasodilator reserve which improves significantly after coronary revascularisation.

  • hibernating myocardium
  • myocardial blood flow
  • heart failure
  • positron emission tomography

Statistics from

Chronic post-ischaemic left ventricular dysfunction in myocardium subtended by a stenotic coronary artery can be improved by revascularisation. This phenomenon of reversible dysfunction has been termed “myocardial hibernation”.1 2 It has been hypothesised that hibernation is an “adaptation” to chronic reduction in resting myocardial blood flow secondary to coronary artery stenosis.2 However, this is contentious as many studies have suggested that basal myocardial blood flow is not significantly reduced even in the presence of severe coronary artery stenoses,3 while there is a progressive reduction of coronary vasodilator reserve with increasing stenosis severity.3 It has also been demonstrated that, in the majority of cases, baseline myocardial perfusion in chronically dysfunctional myocardium which recovers function after revascularisation is similar to that of myocardium with normal contractile function in the same patients4 and to that of normal healthy subjects. Furthermore, non-infarcted, collateral dependent dysfunctional myocardium has normal resting myocardial perfusion but a reduced coronary vasodilator reserve compared to ischaemic but normally functioning segments.5

Our study aimed to assess non-invasively regional myocardial blood flow and coronary vasodilator reserve in hibernating myocardium before and after coronary revascularisation using positron emission tomography (PET), and to compare them with regions with normal contractile function subtended by a normal coronary artery (remote regions) and myocardium of healthy subjects.



The patient population consisted of 30 subjects (28 males; mean (SD) age 56 (10) years) with coronary artery disease (> 6 months) undergoing coronary artery bypass grafting (CABG, 21 patients) or percutaneous transluminal coronary angioplasty (PTCA, nine patients). All patients were in sinus rhythm and had suffered at least one (range 1–3) Q wave myocardial infarction 30 (14) months before the study. Seven patients were diabetic and five were hypertensive. The left ventricular ejection fraction (LVEF) was 30 (11)%. Patients were receiving treatment with angiotensin converting enzyme (ACE) inhibitors (20 patients), diuretics (15 patients), digoxin (5 patients), nitrates (10 patients), calcium channel blockers (13 patients), and β blockers (9 patients). All medical treatment was withdrawn at least 24 hours before the study day both at baseline and follow up. Patients were asked to abstain from drinks containing caffeine for at least 24 hours before the study. Partial data on 19 patients has been reported previously.6

A group of 21 age (53(12) years) and sex matched normal volunteers6 served as controls for the myocardial blood flow and coronary vasodilator reserve measurements. All controls had no history of cardiac disease, a low risk profile, normal physical examination, normal resting ECGs, and negative exercise tests in response to high workloads.

The study was approved by the local ethics committee and written informed consent was obtained by all the patients before the study. The radiation exposure was licensed by the UK administration of radioactive substances advisory committee (ARSAC).


Selective right and left coronary arteriography in multiple views was performed with the Judkins technique. Coronary arteriography was repeated in the nine patients undergoing PTCA three months after the procedure.


LVEF was calculated by radionuclide ventriculography using standard techniques.7 LVEF was reassessed three months following PTCA and six months following CABG. The analysis was performed by two experienced physicians blinded to all clinical details. The inter-observer and intra-observer agreement was assessed8 in a random subset of 10 patients. The mean of the differences in LVEF was 0.05 (1.5)% points and the 95% limits of agreement were 2.9–3%.


Standard views9 were acquired. Resting wall motion/thickening was reassessed three months following PTCA (9 patients) and six months following CABG (21 patients). All the studies were performed by an experienced echocardiographer blinded to all the clinical details of the patients. Images were stored on conventional VHS tapes and analysed off-line by continuous display by two experienced observers who were blinded to the clinical, angiographic, and previous echocardiographic results of the patients. For analysis of wall motion, the left ventricle was divided in 16 segments. Regional wall motion/thickening was assessed for each segment and systolic wall motion was graded using a semiquantitative scoring system (American Society of Echocardiography9): 1 = normal; 2 = hypokinetic; 3 = akinetic; 4 = dyskinetic. Dysfunctional segments improving wall motion at least one point at the follow up study were considered hibernating. In a random subset of 10 patients the inter-observer and the intra-observer κ agreement was assessed: inter-observer κ = 0.82 (95% confidence interval (CI) 0.69 to 0.95); intra-observer κ = 0.90 (95% CI 0.80 to 1.00).


The PET studies were performed in the patients before revascularisation, three months after PTCA or six months after CABG, and in the control subjects using an ECAT 931-08/12 scanner (CTI Inc, Knoxville, Tennessee, USA).10 Myocardial blood flow (MBF, ml/min/g) was measured using H2 15O as previously reported.11 Measurements were made at rest and two minutes after intravenous administration of dipyridamole (0.56 mg/kg over four minutes, MBFdip).12 Coronary vasodilator reserve was calculated as the ratio of post-dipyridamole myocardial blood flow to myocardial blood flow at baseline (MBFdip/MBF).12 Because baseline myocardial blood flow is closely related to the rate–pressure product (RPP),13 an index of myocardial oxygen consumption, basal flow data were also corrected for the RPP using the following equation: MBFcorr = MBF × (mean patient RPP/individual RPP).11

Reconstruction and analysis of the PET images was performed as previously described.11 Images were re-sliced in the short axis view and the left ventricle was divided into 16 segments comparable to the echo images, as previously described.14


Data are expressed as mean (1 SD). Paired data were compared with the paired t test. Simultaneous comparison of more than two sets of data was made using one way analysis of variance, followed by the Tukey-Kramer test to identify the source of variation. Significance was assumed for a probability value of p < 0.05 (two tailed).



A total of 431 left ventricle segments were assessed by PET and echocardiography. Of these, 48 manifested normal contractile function and were subtended by a normal coronary artery (remote regions) and 383 segments were subtended by a stenotic (> 70%) coronary artery. Of these 383 segments, 370 were revascularised. Nine segments were excluded because of restenosis of the subtending vessel three months after PTCA. Of the remaining 361 revascularised segments, 275 were dysfunctional and 86 had normal baseline wall motion. At follow up 163/275 (59%) of dysfunctional segments improved contractile function (hibernating segments) while dysfunction in the remaining 112 segments remained unchanged. The global LVEF increased from 30 (11)% to 37 (10)% (p = 0.0002). LVEF remained unchanged after PTCA (41 (12%)v 43 (10%), p = 0.16) and improved after CABG (24 (7%) v 33 (9%), p = 0.0004).



In the normal subjects, blood flow was homogeneously distributed in the different ventricular regions, and the mean baseline myocardial blood flow was 0.99 (0.21) ml/min/g, increasing to 3.1 (1.3) ml/min/g after dipyridamole, giving a coronary vasodilator reserve of 3.2 (1.5). The rate–pressure product was 8037 (1798). After correction for the rate–pressure product, myocardial blood flow was 1.03 (0.29) ml/min/g and coronary vasodilator reserve was 3.2 (1.6).


In the patients the rate–pressure product before revascularisation was 9337 (2250) and after revascularisation was 8443 (1749) (p = 0.1 v controls and pre-revascularisation). In the hibernating segments the baseline myocardial blood flow was unchanged after revascularisation while there was a significant increase in the post-dipyridamole myocardial perfusion and the coronary vasodilator reserve (table 1, fig 1). In the remote regions there were no changes in baseline and post-dipyridamole myocardial blood flow and coronary vasodilator reserve after revascularisation (table 2).

Table 1

Myocardial blood flow and coronary vasodilator reserve in hibernating segments

Figure 1

Perfusion data on 163 hibernating myocardial segments before (baseline) and after coronary revascularisation. MBF, myocardial blood flow; MBFdip, post-dipyridamole myocardial blood flow; CVR, coronary vasodilator reserve.***p < 0.0001.

Table 2

Myocardial blood flow and coronary vasodilator reserve in remote segments


The baseline myocardial blood flow values before and after revascularisation in hibernating, remote, and control segments were not significantly different (fig 2).

Figure 2

Comparison of myocardial blood flow between hibernating, remote (before and after revascularisation), and control myocardial segments. HIB, hibernation segments before revascularisation; REM, remote segments; -post refers to post-revascularisation.

To identify hibernating segments with abnormally low baseline myocardial blood flow before revascularisation, a cut-off of 0.45 ml/min/g which corresponds to the mean myocardial blood flow of controls (corrected for RPP) minus 2 SD, was used. Only 10/163 (6%) hibernating segments had myocardial blood flow lower than this threshold before revascularisation (fig 3).

Figure 3

Scatterplot showing the distribution of myocardial blood flow (uncorrected and corrected for the rate–pressure product) before revascularisation in the hibernating segments. The thresholds of 0.55 and 0.45 ml/min/g represent the mean value minus 2 SDs of myocardial blood flow in control segments (uncorrected and corrected for the rate–pressure product). MBF, myocardial blood flow uncorrected for the rate–pressure product; MBFcorr, myocardial blood flow corrected for the rate–pressure product.

All pre and post-revascularisation perfusion parameters for hibernating, remote, and control segments are compared in figs 4 and 5.

Figure 4

Comparison of post-dipyridamole myocardial blood flow between hibernating, remote (before and after revascularisation), and control myocardial segments. See fig 2 for key to abbreviations.

Figure 5

Comparison of coronary vasodilator reserve between hibernating, remote (before and after revascularisation), and control myocardial segments. See fig 2 for key to abbreviations. ***p < 0.0001.


The main finding of this study is that revascularisation of hibernating myocardium is associated with an increase in coronary vasodilator reserve, while the baseline myocardial blood flow remains unchanged. Furthermore, our data show that in more than 90% of hibernating segments the myocardial blood flow before revascularisation is within normal range while the coronary vasodilator reserve is significantly lower than in remote regions (in the same patients) and the myocardium of healthy subjects (controls). Previous studies have also demonstrated that the myocardial blood flow of hibernating segments is similar to that of remote regions or healthy control subjects.5 11 15 16 Furthermore, Vanovershelde and colleagues demonstrated in a small and selected group of patients that the pre-revascularisation coronary vasodilator reserve is reduced in dysfunctional myocardium proved to be hibernating by post-revascularisation contractile improvement.5 Our work confirms and expands these findings by providing post-revascularisation data on myocardial blood flow and coronary vasodilator reserve.

Our findings suggest that chronic post-ischaemic left ventricular dysfunction is not necessarily caused by a chronic reduction in resting blood flow (hibernation in its classical definition), but may be related to a reduction in coronary vasodilator reserve. Reduced coronary vasodilator reserve may result in stress induced left ventricular dysfunction. There is evidence both in animals and humans that this left ventricular dysfunction persists in the post-ischaemic period despite absence of irreversible damage and in the presence of normal or near normal myocardial blood, and has been termed myocardial stunning.17 18 In these cases, chronic ventricular dysfunction may be the result of repetitive episodes of imbalance between the supply and demand for oxygen caused by either a temporary increase in myocardial demands (that is, exercise inducible ischaemia) or by oscillations in the blood supply (that is, unstable coronary plaques). Repeated episodes of myocardial ischaemia, occurring during daily life activity, have been documented in patients with chronic stable coronary artery disease.19 These authors demonstrated ischaemic events to be common and often asymptomatic (73% of cases) lasting between one and 90 minutes. Persistent left ventricular dysfunction following exercise has also been detected in patients with coronary artery disease.20 Furthermore, a cumulative adverse effect on left ventricular dysfunction of repetitive episodes of ischaemia has been demonstrated in animal models of progressive coronary stenosis21 22 and confirmed in patients with coronary artery disease.23 24 Repetitive episodes of exercise induced ischaemia, followed by stunning, may thus result in a cumulative effect on post-ischaemic myocardial dysfunction, leading to a chronic state of dysfunction.

It could be hypothesised that improvement of contractile function in hibernating myocardium following coronary revascularisation is caused by the improvement in coronary vasodilator reserve, with a reduction of the “repetitive ischaemic events”. This may trigger cellular mechanisms to “revert” the ultrastructural and metabolic adaptations resulting from repetitive stunning, thus resulting in an improvement in contractility.

We have used H2 15O for the measurement of myocardial blood flow; this tracer—unlike13NH3 —is not taken up by scar tissue, thus avoiding the dilution effect of scar.4

In our study, both the coronary vasodilator reserve of left ventricle segments subtended by an angiographically normal coronary vessel and with normal contractile function (remote regions), and that of hibernating segments after revascularisation, was significantly lower than the coronary vasodilator reserve of controls. These findings are consistent with previous studies demonstrating an abnormal coronary vasodilator reserve in patients with coronary artery disease, even in regions subtended by normal epicardial coronary vessels.12 25 Although the mechanism underlying this phenomenon remains unknown, others have explained it as a manifestation of microvascular endothelial dysfunction which affects patients with coronary artery disease.26


In this study we assessed myocardial blood flow, coronary vasodilator reserve, and regional left ventricular function at a single postoperative time point. Serial temporal studies of these parameters could have provided some insight into the time course of improvement in coronary vasodilator reserve and left ventricular function. Although our study demonstrates that hibernating myocardium is associated with a reduced coronary vasodilator reserve, because of the resolution limitations of the current PET scanners we were unable to measure epicardial and endocardial myocardial blood flow and coronary vasodilator reserve, and thus ascertain the implications of these data for the pathophysiology of hibernation. The choice of 0.45 ml//min/g as a lower limit of normal myocardial blood flow is arbitrary and reflects the difficulty of defining normal myocardial blood flow. Studies have demonstrated the significant heterogeneity of myocardial blood flow in normal subjects.27 28


View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.